Myoderm is a leader in the sourcing, distribution, and management of commercial pharmaceutical products and supplies for clinical trials. Our clients span the globe and include biotech companies, CROs, clinical trial packagers, and a majority of the world's top 10 pharmaceutical companies. Myoderm has established a track record of exceptional performance. With our deep expertise, innovative approach, and commitment to personalized service, we provide the optimal drug supply solution for our customers' global clinical studies.
Patricia Hurley, Joan Boren and Costantino Congiatu, PPD||June 2, 2015 More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry.
Stephanie Mowery, Sherri Rinker, Franklin Spriggs and Bo Kowalcyk , AIT Bioscience||June 2, 2015 Moving forward clinical studies will have to include a comparative assessment of
pharmacokinetics and immunogenicity to the original reference biologic drug
Tim Wright, Editor||May 6, 2015 Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers, to help us benchmark the state of the pharmaceutical outsourcing industry.
Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences||January 29, 2015 CRO industry generates healthy partnerships through co-development of drugs,
diagnostics and demand for functional services.
Alex McClung, Xcelience||November 13, 2014 Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. This is the second in a series of articles outlining specific quality concerns associated with packaging clinical trial supplies and how to effectively manage those concerns.
David Agrella, Bryan Haas, Pharm.D., Timothy King, Dr.P.H. and Scott Maisto , PPD||November 13, 2014 This article discusses the advantages to both biopharmaceutical companies and their vendors of moving outsourcing spend to a commercial model focused on the desired deliverable and not the level of effort required to achieve the deliverable.